U.S. Support for WHO-Convened Phase 2 COVID Origins Study
Phase 1 of the WHO-convened COVID-19 origins study was insufficient and inconclusive. We call for a timely, transparent, evidence-based, and expert-led Phase 2 study, including in the People’s Republic of China. It is critical that China provides independent experts full access to complete, original data and samples relevant to understanding the source of the virus and the early stages of the pandemic. We appreciate the WHO’s stated commitment to move forward with Phase 2 of the COVID-19 origins study, and look forward to an update from Director General Tedros.